Sun Pharma to buy Organon in $11.75B deal, expanding global reach

Sun Pharma to buy Organon in $11.75B deal, expanding global reach Apr 26, 2026, 8:14 PM ETOrganon & Co. (OGN) StockMRKBy : Rob Williams, SA News Editor Comments (2) Sun Pharmaceutical Industries on Sunday said it agreed to acquire Organon & Co. (OGN) in an all-cash transaction valuing the company at an enterprise value of $11.75 billion, marking one of the largest healthcare deals of the year. Under the Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters